Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Volition & Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan – video

Key Takeaway: Volition Veterinary has partnered with Fujifilm Vet Systems to launch the Nu.Q® Vet Cancer Test in Japan. This supply agreement allows Fujifilm to offer cancer screening services for dogs through its network of laboratories. The initiative aims to enhance cancer detection in veterinary practices across Japan.
Price reaction · baseline $17 (2024-03-19 close) · hit pre-market · 7 other VNRX headline(s) in the window, move may be shared
day 0 close
-5.9%
day 1
-14.1%
day 3 · peak
-15.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Launch of Nu.Q® Vet Cancer Test in Japan.
  • Collaboration with Fujifilm Vet Systems enhances market reach.
  • Improves cancer detection capabilities for veterinarians.

Full Press Release Details

Dr. Tom Butera, Chief Executive Officer of Volition Veterinary, outlines Volition’s supply agreement with Fujifilm Vet Systems, a leading veterinary diagnostic laboratory service, to launch the Nu.Q ® Vet Cancer Test to veterinarians in Japan.
Our supply agreement enables Fujifilm Vet Systems to sell and perform cancer screening services for dogs using the Nu.Q ® Vet Cancer Test throughout its network of central reference laboratories in Japan, and aid cancer detection.
• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the Nu.Q® Vet Cancer Test?

The Nu.Q® Vet Cancer Test is a diagnostic tool for detecting cancer in dogs.

Who is partnering with Volition Veterinary?

Volition Veterinary is partnering with Fujifilm Vet Systems for the test launch.

Where will the Nu.Q® Vet Cancer Test be available?

The test will be available in Japan through Fujifilm's network of laboratories.

What is the purpose of the supply agreement?

The agreement allows Fujifilm to sell and perform cancer screening services.

Last updated: Mar 20, 2024